Lung Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers
Recruiting
  • Carcinoma, Small Cell
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recruiting
  • Prostate Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-04-07
    Apr 7, 2022
    U
    Testing Radon Com Methods: Clinical Trial Smartphone App vs Print Brochures
    Not yet recruiting
    • Lung Cancer
    • The radon app
    • Print brochure
    • (no location specified)
    2022-03-31
    Mar 31, 2022
    M
    A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation
    Recruiting
    • Lung Cancer
    • AMG 510
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    2022-03-30
    Mar 30, 2022
    H
    PeRsonalizing the Approach to the Oncologic Frail Individual Through Tailored Assessment and Intervention (PROFIT Study)
    Enrolling by invitation
    • Older Adults
    • +4 more
    • Intervention group
    • Control group
    • Andorra, Andorra
    • +2 more
    2022-03-31
    Mar 31, 2022
    T
    Observational Study of the Efficacy and Safety of Anlotinib Combined With Penpulimab in Elderly Lung Cancer Patients
    Not yet recruiting
    • Lung Cancer
    • +4 more
    • Anlotinib and Penpulimab
    • Xinxiang, Henan, China
      Department of Oncology, The First Affiliated Hospital of Xinxian
    2022-04-01
    Apr 1, 2022
    A
    ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy
    Not yet recruiting
    • Lung Cancer
    • +2 more
    • ChatBot
    • (no location specified)
    2022-04-07
    Apr 7, 2022
    O
    A Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies in Patients Undergoing Routine Surgery
    Recruiting
    • Lung Cancer
    • Philadelphia, Pennsylvania
    • +1 more
    2022-04-07
    Apr 7, 2022
    N
    Mobile Sensor Technologies to Assess General Symptomology of People With Cancer
    Enrolling by invitation
    • Neoplasms
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-04-07
      Apr 7, 2022
      N
      LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
      Recruiting
      • Lung Cancer
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-04-07
      Apr 7, 2022
      I
      Personalised Diet, Exercise and Emotional Support for Lung Cancer Patients Having Chemotherapy or Radiotherapy Treatment
      Not yet recruiting
      • Lung Cancer
      • Assessment of level of readiness and need for personalised prehabilitation
      • +2 more
      • London, United Kingdom
        Imperial College Healthcare NHS Trust
      2022-04-01
      Apr 1, 2022
      N
      Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for, Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas
      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • +4 more
      • Decitabine (DAC)
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-04-07
      Apr 7, 2022
      N
      Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China
      Active, not recruiting
      • Lung Cancer
        • Beijing, China
          Cancer Institute of the Chinese Academy of Medical Sciences
        2022-04-07
        Apr 7, 2022
        N
        Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
        Active, not recruiting
        • Prostate Cancer
        • +4 more
          • Bethesda, Maryland
            National Cancer Institute (NCI), 9000 Rockville Pike
          2022-04-07
          Apr 7, 2022
          N
          Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
          Recruiting
          • Prostate Cancer
          • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            2022-04-07
            Apr 7, 2022
            N
            A Nested Case-Control Study of Lung Cancer and Diesel Exhaust Among Non-Metal Miners
            Active, not recruiting
            • Lung Cancer
              • Rockville, Maryland
                Westat Inc
              2022-04-07
              Apr 7, 2022
              P
              Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging
              Recruiting
              • Lung Cancer
              • Neuroendocrine Neoplasm
              • Beijing, Beijing, China
                Peking Union Medical College Hospitall, Chinese Academy of Medic
              2022-03-30
              Mar 30, 2022
              V
              First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer
              Active, not recruiting
              • Lung Cancer
              • Aarhus, Denmark
              • +9 more
              2022-04-06
              Apr 6, 2022
              V
              Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities
              Not yet recruiting
              • Lung Cancer
              • +6 more
              • (no location specified)
              2022-04-04
              Apr 4, 2022
              G
              A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
              Not yet recruiting
              • Lung Cancer
              • Provider Prompt & Patient Outreach and Education
              • Washington, District of Columbia
                MedStar Health
              2022-03-24
              Mar 24, 2022
              M
              RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
              Not yet recruiting
              • Adenocarcinoma of Lung
              • Lung Cancer
              • Oral Restorative Microbiota Therapy (RMT) Capsules
              • +3 more
              • Minneapolis, Minnesota
                Masonic Cancer Center, University of Minnesota
              2022-04-04
              Apr 4, 2022
              J
              Comparison of Emergence and Oxygenation During One-lung Ventilation With Desflurane and Propofol Anesthesia
              Active, not recruiting
              • Lung Cancer
              • Bunkyo-ku, Tokyko, Japan
                University of Juntendo
              2022-04-02
              Apr 2, 2022
              U
              Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
              Not yet recruiting
              • Metastatic Cancer
              • +7 more
              • Standard of Care Chemotherapy
              • +7 more
              • (no location specified)
              2022-04-01
              Apr 1, 2022
              S
              AI-EBUS-Elastography for LN Staging
              Recruiting
              • Artificial Intelligence
              • +4 more
              • EBUS-Elastography
              • Hamilton, Ontario, Canada
                St. Joseph's Healthcare Hamilton
              2022-03-31
              Mar 31, 2022
              A
              Reveal the Patterns of Presentation, Management and Outcome of Patients With SCLC and Stage III NSCLC in Saudi Arabia:
              Recruiting
              • Lung Cancer
                • Riyadh, Saudi Arabia
                • +2 more
                2022-03-23
                Mar 23, 2022